With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world
A clinical trial with Heberferon will begin this year in Cuba in about 300 patients with renal carcinoma, announced Dr. Iraldo Bello, expert who developed the product at the Center for Genetic Engineering and Biotechnology
A therapeutic vaccine aimed at reducing the viral load of patients with Human Immunodeficiency Virus (HIV), which has an impact on the quality of life of patients, is currently in phase one of the clinical trial, in which its safety is studied
Radio Rebelde. 23 # 258 % L y M. Vedado. Plaza de la Revolucion Havana City, Cuba CP. 10400.
Webmaster: Yirian García de la Torre. Journalist: Liannis Mateu Francés
- Malvy Souto López - Ruth Soto Falcón.
Photojournalist: Abel Rojas Barallobre. Programmer: Mabel Peña Soutuyo. Developed by
Radio Rebelde Web Team